Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Antiemetic Support During Canine Cancer Treatment
Antiemetic therapy aims to prevent or control nausea and vomiting from chemotherapy, radiation fields, anesthesia, medications, the tumor, or another disease. Drug choice and timing depend on the…
Read moreMaropitant for Nausea and Vomiting Support in Cancer Care
Maropitant is a prescription antiemetic used for selected dogs and cats, but controlling vomiting does not identify or resolve every cause of nausea or gastrointestinal disease.
Read moreOndansetron for Persistent Nausea: Role and Interaction Review
Ondansetron is a serotonin-receptor antiemetic used by veterinarians for selected nausea and vomiting, often when one pathway or medicine is not enough.
Read moreMetoclopramide: Antiemetic and Motility Questions in Oncology
Metoclopramide has antiemetic and upper-gastrointestinal motility effects, making obstruction, neurologic history, cause, route, and interactions central to safe selection.
Read moreMirtazapine for Appetite Support: Nausea-First and Interaction Boundary
Mirtazapine may support appetite in selected dogs or cats, but nausea, pain, obstruction, oral disease, diet, organ function, and serotonergic interactions need attention first.
Read more
Named profile Prednisolone in Feline and Canine Oncology: Uses and Safety BoundariesRepresentative category illustration – no product packaging is shown.Prednisolone in Feline and Canine Oncology: Uses and Safety Boundaries
prednisolone is covered as glucocorticoid with lympholytic, anti-inflammatory and supportive-care roles, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Acid-Suppression Medicines in Veterinary Oncology: Rational-Use ProfileRepresentative category illustration – no product packaging is shown.Acid-Suppression Medicines in Veterinary Oncology: Rational-Use Profile
proton-pump inhibitors and histamine-2 receptor antagonists is covered as gastrointestinal supportive-medicine class, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Cobalamin (Vitamin B12) in Canine and Feline Oncology SupportRepresentative category illustration – no product packaging is shown.Cobalamin (Vitamin B12) in Canine and Feline Oncology Support
cobalamin (vitamin B12) is covered as nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement, with species, evidence, regulatory, safety, interaction and monitoring boundaries…
Read more
Named profile Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and CyclophosphamideRepresentative category illustration – no product packaging is shown.Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and Cyclophosphamide
mesna (sodium 2-mercaptoethane sulfonate) is covered as protocol-linked uroprotective medicine; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Furosemide as a Cyclophosphamide Uroprotection Adjunct in DogsRepresentative category illustration – no product packaging is shown.Furosemide as a Cyclophosphamide Uroprotection Adjunct in Dogs
furosemide used as a protocol adjunct is covered as loop diuretic used within selected canine cyclophosphamide protocols; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring…
Read more
Named profile H1 and H2 Blockade Around Mast-Cell Degranulation RiskRepresentative category illustration – no product packaging is shown.H1 and H2 Blockade Around Mast-Cell Degranulation Risk
H1-receptor and H2-receptor blocking companion medicines is covered as protocol-linked supportive medicines; not direct antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led…
Read more